SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1F81C0657F6829C175230C5F87AC1DB6CA3F7D1D84BBAD425BF4C83C140EBD1F2B255974C3D7D502EB3C43F913419F3C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1F81C0657F6829C175230C5F87AC1DB6CA3F7D1D84BBAD425BF4C83C140EBD1F2B255974C3D7D502EB3C43F913419F3C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1F81C0657F6829C175230C5F87AC1DB6CA3F7D1D84BBAD425BF4C83C140EBD1F2B255974C3D7D502EB3C43F913419F3C
http://www.w3.org/2000/01/rdf-schema#comment
"Treatment with myricetin led to G2/M cell cycle arrest in T24 bladder cancer cells by downregulation of Cyclin B1 and cyclin-dependent kinase cdc2."
xsd:string
http://purl.uniprot.org/uniprot/#_5777ABB45EF0856292BABB1BA8A6B20E79C6428CA5474FCF7D5E1023B3930F96730D03EA213C24BA312A8F82B2D69C12
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1F81C0657F6829C175230C5F87AC1DB6CA3F7D1D84BBAD425BF4C83C140EBD1F2B255974C3D7D502EB3C43F913419F3C
http://purl.uniprot.org/uniprot/P14635
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1F81C0657F6829C175230C5F87AC1DB6CA3F7D1D84BBAD425BF4C83C140EBD1F2B255974C3D7D502EB3C43F913419F3C
http://purl.uniprot.org/uniprot/#_P14635-mappedCitation-22482362
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1F81C0657F6829C175230C5F87AC1DB6CA3F7D1D84BBAD425BF4C83C140EBD1F2B255974C3D7D502EB3C43F913419F3C